Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$96.98 - $155.02 $17,262 - $27,593
-178 Reduced 3.76%
4,553 $477,000
Q2 2024

Aug 20, 2024

BUY
$94.79 - $142.19 $448,451 - $672,700
4,731 New
4,731 $672,000
Q3 2023

Nov 14, 2023

SELL
$154.04 - $200.48 $195,168 - $254,008
-1,267 Reduced 27.38%
3,360 $547,000
Q2 2023

Aug 01, 2023

SELL
$113.54 - $183.33 $464,832 - $750,553
-4,094 Reduced 46.94%
4,627 $848,000
Q1 2023

May 05, 2023

SELL
$78.2 - $133.45 $938 - $1,601
-12 Reduced 0.14%
8,721 $1.16 Million
Q4 2022

Feb 17, 2023

BUY
$50.79 - $86.52 $443,549 - $755,579
8,733 New
8,733 $693,000
Q2 2022

Jul 22, 2022

BUY
$51.63 - $72.3 $346,127 - $484,699
6,704 New
6,704 $368,000

Others Institutions Holding ACLS

About AXCELIS TECHNOLOGIES INC


  • Ticker ACLS
  • Exchange NASDAQ
  • Sector Technology
  • Industry Semiconductor Equipment & Materials
  • Shares Outstandng 33,033,800
  • Market Cap $2.11B
  • Description
  • Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecy...
More about ACLS
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.